Manitoba versus Minnesota only as we were trying to figure out at one point why the hell Canada is relatively expensive for pharmaceutical care even though their drug prices are significantly less as compared with other national health systems. Manitoba is both MUCH more regulation heavy from the business end with lower returns on capital. However, there is a lower population per script requirement in Manitoba from comparing numbers at one point. I'd say that Canada is still in the early-90s compared to the States in terms of efficiency and throughput. In terms of profit, who knows. The federal CHA and the provincial governments (and especially Quebec) have rather odd arrangements for their markets and services. More or less, you end up dealing with the province when a pharmacy is to be opened, and prices are directly regulated by the provincial authority. There is more or less a provincial P&T committee where no two provinces have complete agreement.